Xylem (NYSE:XYL) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Xylem (NYSE:XYL) issued its earnings results on Tuesday. The industrial products company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.04, Briefing.com reports. The business had revenue of $2.17 billion during the quarter, compared to analysts’ expectations of $2.14 billion. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The company’s revenue for the quarter was up 26.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.98 EPS.

Xylem Price Performance

Xylem stock opened at $132.99 on Friday. Xylem has a 12-month low of $87.59 and a 12-month high of $146.08. The stock has a market capitalization of $32.30 billion, a P/E ratio of 47.45, a P/E/G ratio of 2.36 and a beta of 1.04. The firm’s 50-day moving average is $137.77 and its two-hundred day moving average is $130.93. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.85 and a quick ratio of 1.22.

Xylem Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 27th. Shareholders of record on Thursday, May 30th were paid a dividend of $0.36 per share. The ex-dividend date of this dividend was Thursday, May 30th. This represents a $1.44 annualized dividend and a dividend yield of 1.08%. Xylem’s dividend payout ratio is currently 51.25%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on XYL shares. Oppenheimer increased their price target on shares of Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Stifel Nicolaus upped their price objective on shares of Xylem from $170.00 to $172.00 and gave the stock a “buy” rating in a research report on Wednesday. Citigroup upped their price objective on shares of Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research report on Monday, April 8th. Royal Bank of Canada upped their price objective on shares of Xylem from $160.00 to $163.00 and gave the stock an “outperform” rating in a research report on Wednesday. Finally, Mizuho increased their price target on shares of Xylem from $110.00 to $135.00 and gave the company a “neutral” rating in a report on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and a consensus target price of $146.08.

Insiders Place Their Bets

In other Xylem news, SVP Rodney Aulick sold 21,800 shares of the firm’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the sale, the senior vice president now directly owns 76,287 shares of the company’s stock, valued at approximately $10,604,655.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the completion of the transaction, the chief accounting officer now owns 3,536 shares of the company’s stock, valued at $490,195.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Rodney Aulick sold 21,800 shares of the stock in a transaction on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the sale, the senior vice president now directly owns 76,287 shares of the company’s stock, valued at approximately $10,604,655.87. The disclosure for this sale can be found here. 0.27% of the stock is owned by corporate insiders.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.